New View Surgical, Inc. Names Bryce Klontz as President & CEO

February 2016


New View Surgical, Inc., an early-stage surgical imaging company in Boston, Massachusetts, announced today that it has named Bryce Klontz as President &CEO, effective immediately. Mr. Klontz is an accomplished global sales and marketing executive, having built and led commercial teams in the US, Europe and Asia. Most recently, Mr. Klontz was the Vice President of Commercial Strategy, Emerging Markets at Covidien, PLC where he led efforts to build commercial capabilities within the $1.5B+ Asia, Latin America, Emerging Europe, Middle East and Africa geographies. Mr. Klontz spent 14 years at Covidien in various leadership roles including Marketing Director in both the US and Europe, as well as 3 years as Vice President, Surgical Devices Business Unit, in Asia. Mr. Klontz also served as the global post-M&A integration lead for two of Covidien's most impactful acquisitions. Earlier in his career, Mr. Klontz played a pivotal role in the global launch of The CO2 Heart Laser System. Mr. Klontz received his MBA in marketing and finance from Carroll School of Management at Boston College and a Bachelor's degree from Northwestern University.

By Shane Johnson February 22, 2023
New View Surgical is proud to be recognized as one of the Top 10 Companies to Watch in 2023 by Medtech Outlook Magazine
December 6, 2022
New View Surgical Announces First Commercial Case of the VisionPort™ System, Performed by David Earle, M.D., F.A.C.S.
By Bryce Klontz November 21, 2022
New View Surgical, Inc. Closes $12.1M Series B-1 Financing, Readies Limited Market Release of its VisionPort™ System For Minimally Invasive Surgery
September 20, 2022
How to Find Product-Market Fit by Going Deep Versus Wide: Interview with New View Surgical CEO Bryce Klontz
June 16, 2022
New View Surgical, Inc. Strengthens Executive Leadership Team with Appointment of Shane Johnson as Chief Commercial Officer
November 3, 2021
New View Surgical, Inc. Closes $9M Series B Financing to Fund Initial Market Release of its VisionPort™ System for Minimally Invasive Surgery
July 15, 2021
In this episode, Giovanni and Bryce discuss raising capital from angel groups, the differences between angels and VCs, east vs. west coast investors and more.
June 23, 2021
New View Surgical, Inc. Announces FDA Clearance of its VisionPort™ System for Minimally Invasive Surgery 
December 17, 2020
New View Surgical, Inc. Recognized as ‘Most Valued Company’ at virtual Keiretsu Forum Investor Capital Expo
June 17, 2019
New View Surgical, Inc. Closes Series A Round of Financing
MORE POSTS
Share by: